Boston Specialists, 65 Harrison Ave Suite #201, Boston, MA, 02111, USA.
BMC Gastroenterol. 2023 Mar 9;23(1):60. doi: 10.1186/s12876-023-02703-9.
First-line treatment of eosinophilic esophagitis (EoE) includes monotherapy with proton-pump inhibitors (PPIs), food elimination diet (FED), or topical corticosteroids. Current guidelines suggest patients with EoE should continue any responsive first-line monotherapies. However, the efficacy of FED monotherapy in patients with EoE responsive to PPI monotherapy has not been well studied. Our study aimed to investigate how attempting FED monotherapy after experiencing remission of EoE after PPI monotherapy influenced long-term EoE management.
We retrospectively identified patients with EoE responsive to PPI monotherapy who trialed FED monotherapy. We then employed a mixed method approach to a prospective cohort. Selected patients were observed long term for quantitative outcomes, while qualitative results were obtained from patient surveys regarding their perspectives on the trial of FED monotherapy.
We identified 22 patients who trialed FED monotherapy after experiencing remission of EoE following PPI monotherapy. Of these 22 patients, 13 had remission of EoE with FED monotherapy, while 9 had re-activation of EoE. Out of 22 patients, 15 were enrolled in a cohort for observation. No exacerbations of EoE occurred while on maintenance treatment. Most patients stated that they would recommend this process to others with EoE (93.33%) and that trial of FED monotherapy helped them identify a treatment plan that aligned with their lifestyle (80%).
Our work shows that FED monotherapy can be an effective alternative for patients with EoE responsive to PPI monotherapy that may improve patient quality of life, suggesting alternative treatment options should be considered for monotherapy-responsive EoE.
嗜酸性食管炎(EoE)的一线治疗包括质子泵抑制剂(PPIs)单药治疗、食物排除饮食(FED)或局部皮质类固醇治疗。目前的指南建议 EoE 患者应继续使用任何有反应的一线单药治疗。然而,对于对 PPI 单药治疗有反应的 EoE 患者,FED 单药治疗的疗效尚未得到很好的研究。我们的研究旨在探讨在经历 PPI 单药治疗缓解 EoE 后尝试 FED 单药治疗如何影响 EoE 的长期管理。
我们回顾性地确定了对 PPI 单药治疗有反应的 EoE 患者,这些患者尝试了 FED 单药治疗。然后,我们采用混合方法对前瞻性队列进行研究。选择的患者接受了长期的定量观察,同时通过患者调查获得了他们对 FED 单药治疗试验的看法的定性结果。
我们确定了 22 例在经历 PPI 单药治疗缓解 EoE 后尝试 FED 单药治疗的患者。在这 22 例患者中,有 13 例患者在 FED 单药治疗下 EoE 缓解,而 9 例患者 EoE 再次激活。在 22 例患者中,有 15 例患者被纳入观察队列。在维持治疗期间,没有 EoE 恶化。大多数患者表示他们会向其他 EoE 患者推荐这一过程(93.33%),并且 FED 单药治疗试验帮助他们确定了符合其生活方式的治疗计划(80%)。
我们的工作表明,FED 单药治疗可以作为对 PPI 单药治疗有反应的 EoE 患者的有效替代方案,可能改善患者的生活质量,这表明对于对单药治疗有反应的 EoE 应考虑替代治疗方案。